Falls in Older Adults With Cancer: Evaluation by Oncology Providers by Guerard, Emily J. et al.
Original Contribution
Falls in Older Adults With Cancer: Evaluation by
Oncology Providers
By Emily J. Guerard, MD, Allison M. Deal, MS, Grant R. Williams, MD, Trevor A. Jolly, MBBS,
Kirsten A. Nyrop, PhD, and Hyman B. Muss, MD
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC
See accompanying commentary on page 475
Abstract
Purpose: Falls in older adults are common. Screening for falls
is quick, simple, and important because falls increase the risk of
morbidity and mortality in older patients with cancer. The aim of
this study was to evaluate oncology providers’ recognition of and
response to falls in older patients with cancer.
Materials and Methods: From a sample of older patients
with cancer who completed a geriatric assessment blinded to
oncology providers, we identified patients who self-reported falls
within the past 6 months. Their history and physical and/or clinic
notes completed by an oncology provider were reviewed for the
following: documentation of falls, gait assessment, referral to
geriatrics or physical and/or occupational therapy, and measure-
ment of 25-hydroxy vitamin D level.
Results: In our sample of older patients with cancer who re-
ported at least one recent fall (N  125), the average age was 72
years (range, 65 to 93 years), 78% were female, and 62% had a
breast cancer diagnosis. Chart reviews showed that 13 (10%)
had falls documented, 25 (20%) had a gait assessment, eight
(6%) were referred, and 21 (17%) had vitamin D level measured.
Conclusion: We found that only 10% of older patients with
cancer who self-reported a recent fall had appropriate medical
record documentation. Oncologists are often the primary care
providers for older patients and are largely unfamiliar with the
frequency and impact of falls in this population. There is a need to
increase awareness of falls prevalence and consequences
among oncology providers in order to provide timely interven-
tions to reduce the risks associated with falls.
Introduction
Falls are a major cause of morbidity and mortality in persons
65 years or older, with as many as one in three community-
dwelling elders reporting a fall in the previous year. 1-4 This
is likely to be an underestimate, as there is evidence that less
than 50% of patients voluntarily report a fall to their health
care providers.5 Risk factors for falls among older persons
include a prior fall, visual impairment, certain medications
or polypharmacy, gait/balance abnormalities, muscle weak-
ness, neurologic impairments, cardiac rate or rhythm distur-
bances, postural hypotension, improper footwear, and
environmental hazards.4,6,7 Falls are of concern because 20%
to 30% of falls in the elderly lead to serious injuries that in
turn can result in declines in function and an increased like-
lihood of institutionalized care.3,8 Even if a fall does not
result in an injury, it can precipitate a fear of falling that can
lead to reduced activity and a decrease in physical func-
tion.9,10 The American Geriatrics Society recommends that
all older adults under the care of a health professional be
screened for falls at least annually.7
There is a particular need for falls screening among older pa-
tients with cancer, as cancer is largely a disease of aging. Currently,
the median age of a new cancer diagnosis is 66 years, with the
majority of cancer deaths occurring after the age of 70.11 The older
adult population is rapidly increasing in the United States, from an
estimated 40.3 million in 2010 to a projected 74 million by
2030.12,13 In addition, the incidence of cancer in older adults is
expected to increase considerably as the baby boomer generation
ages.14 Given these statistics, there is now and will continue to be a
need for oncology providers to assess and intervene on common
geriatric syndromes such as falls.
Older patients with cancer have additional risk factors for
falls when compared with the general population of older
adults, as toxicity from cancer treatments can increase the risk of
falls.15,16 In one study, the presence of falls was shown to be
associated with an increased risk of serious chemotherapy tox-
icity in older patients with cancer.17 Falls evaluation is critical
for older patients with cancer, as it provides a means to gauge
the patient’s functional status18 and may be an important con-
sideration with regard to treatment decisions.17
Screening for falls can be as simple as inquiring about the
number of falls the patient has experienced in the past 6
months and documenting this as part of the clinical evalua-
tion. Early identification of falls presents an opportunity to
initiate timely interventions. Meta-analyses have shown that
multifactorial interventions can be effective in reducing falls
risk in older adults.19,20 Falls interventions can potentially
lead to improvements in function, treatment tolerability,
and overall quality of life for older patients with cancer.
Whether oncology providers are documenting falls in the
medical record and/or providing the appropriate interventions
or services to older adults who fall is unknown. The aim of this
study was to evaluate oncology providers’ recognition and re-
sponse to falls in older patients with cancer.
Health Care Delivery
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Materials and Methods
Sample
The sample for this study was identified from an institutional
database called “Carolina Senior: University of North Carolina
Registry for Older Patients.” The University of North Carolina
Institutional Review Board approved the Carolina Senior Reg-
istry (CSR) in 2009 (Clinical Trial No. NCT01137825). The
CSR contains cross-sectional geriatric assessment (GA) data on
patients 65 years or older seen at the North Carolina Cancer
Hospital, a large academic comprehensive cancer center, and 11
community oncology clinics throughout the state. Informed
consent was obtained from each participant before they com-
pleted the GA, which was administered by trained clinical re-
search assistants to each patient once during various treatment
phases. The GA used for the CSR was developed by Hurria et al
and includes valid and reliable measures of geriatric domains
pertaining to physical function, independent activities of daily
living (IADL), medications, medical comorbidity, nutritional
status, psychosocial status, social support, and cognitive func-
tion.21 This GA has also been integrated into oncology cooper-
ative group trials and has been shown to be feasible in academic
and community oncology clinics.22,23
Measures
As of October 2013, the CSR contained GA data for 1,035
patients with cancer. Only patients seen at the North Carolina
Cancer Hospital—a total of 528—were included in our anal-
ysis. The patients recruited from community oncology clinics
were excluded from our analysis because of limited access to
their patient charts, which were needed for our review. The
patient self-report section of the GA includes the question,
“How many falls have you had in the past 6 months?” The
patient records a number in the box provided to answer this
question. The history and physical and/or clinic notes com-
pleted by an oncology provider within 6 months after comple-
tion of the GA were retrospectively reviewed for the following:
(1) documentation of falls, (2) documentation of a gait assess-
ment, (3) new referrals to geriatrics or physical therapy (PT)
and/or occupational therapy (OT), and (4) measurement of
25-hydroxy vitamin D level. These outcome variables were se-
lected because (1) falls are a major cause of morbidity and
mortality 2,3 and therefore should be screened for by oncology
providers and documented in the medical record; (2) gait as-
sessment can identify patients in need of further intervention7;
(3) PT, OT, and/or geriatrics referrals represent important in-
terventions for patients with a history of falls24,25; and (4) low
vitamin D levels are commonly found in older adults,26 and
supplementation has been shown to reduce falls risk.7,27-29 We
note that oncology providers did not have access to the findings
from GA evaluations conducted on their patients for the CSR.
The GA data were collected independently for the purpose of a
registry and were not at any time shared with the patient’s
treating oncology provider.
To describe the functional status of the 125 patients who
self-reported falls, we analyzed the following GA data: self-
reported Karnofsky performance status,30 IADL,31 ability to
walk one block, and ability to climb one flight of stairs. IADL
items inquire about the patient’s ability to use the telephone,
avail themselves of transportation, shop, prepare meals, do
housework, manage their own medications, and manage their
own finances.
Data Analysis
Frequencies and percentages are reported, and exact 95% bino-
mial CIs are provided for key estimates. All analyses were con-
ducted using SAS Statistical Software v9.3 (SAS Institute, Cary,
NC).
Results
Of the 528 patients with cancer in the CSR seen at the North
Carolina Cancer Hospital, 125 (24%) reported at least one fall
in the previous 6 months. Of these 125 patients, 67 (54%) had
one fall, 31 (25%) had two falls, and 27 (22%) had three or
more falls.
Patient characteristics of the 125 patients who self-reported
at least one fall are shown in Table 1. The median age was 71
years, with an age range of 65 to 93 years and average age of 72
years. Most patients were female (n  97; 78%), white (n 
108; 86%), and had a breast cancer diagnosis (n  77; 62%).
Close to half (n  58; 46%) were assessed during active cancer
treatment.
Table 2 describes the functional characteristics of the 125
patients. Forty-four patients (35%) had a self-reported Karnof-
sky performance status score of 70% or less, which indicates
functional impairment. Forty-four patients (35%) were limited
in their ability to walk one block, and 56 (45%) were limited in
their ability to climb one flight of stairs.
Findings from our chart review of the 125 patients with a
falls history are summarized in Table 3. Only 13 charts (10%;
95% CI, 6% to 17%) contained oncology provider notes doc-
umenting the presence of falls, either during the initial encoun-
ter or within 6 months after completion of the GA. There were
three documented referrals from the oncology providers who
recorded falls in the chart, five patients had their vitamin D
levels measured, and three patients had a gait assessment
documented.
Of the 125 patients who self-reported a recent fall, a gait
assessment was documented for 25 patients (20%; 95% CI,
13% to 28%), and the majority were recorded as “normal” or
“unremarkable.” Referrals to PT and/or OT were made for four
patients (3%; 95% CI, 1% to 8%); four referrals (3%; 95% CI,
1% to 8%) were made to geriatrics. Two of the PT/OT referrals
were for lymphedema. Of the eight referrals to PT/OT and
geriatrics, one patient received a referral to both, so the rate of
any referral was 6%. Levels of 25-hydroxy vitamin D were
measured for 21 patients (17%; 95% CI, 11% to 25%), pri-
marily within the context of assessing bone health.
Discussion
In our sample of older patients with cancer seen in an academic
comprehensive cancer center, we found that oncology providers
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rarely recorded or responded to falls in their older patients. We
found minimal evidence of documentation of falls in the pa-
tients’ medical records or actions that would suggest oncology
provider awareness of interventions that could lower the risk of
future falls. We found that no more than 17% of older patients
with cancer who experienced falls had appropriate medical re-
cord documentation or referrals. Because oncology providers
did not have access to findings from the GA, this study demon-


























During treatment* 58 (46)
Post-treatment 37 (30)
Educational level†
Less than high school 12 (10)
High school graduate 51 (41)
Associate/bachelor’s 37 (30)








Disabled, medical leave 19 (16)
Retired, homemaker 91 (75)
* During treatment denotes patients receiving chemotherapy, radiation, and other
forms of cancer-directed therapy excluding endocrine therapy.
† Not all percentages add to 100% as a result of rounding.
Table 2. Functional Characteristics (N  125)
Characteristic No. (%)
No. of self-reported falls*
1 67 (54)
2 31 (25)
 3 27 (22)
Self-reported KPS, %*
100, normal 28 (22)
90, carry on normal activity 29 (23)
80, normal activity with effort 24 (19)
70, care of self 9 (7)
60, require occasional assistance 28 (22)
50, require considerable assistance 5 (4) 2 (2)
40, disabled
Use the telephone
Without help 120 (96)
With some help 4 (3)
Unable 1 (1)
Avail transportation
Without help 95 (76)
With some help 28 (22)
Unable 2 (2)
Shop
Without help 92 (74)
With some help 29 (23)
Unable 4 (3)
Prepare meals
Without help 98 (78)
With some help 21 (17)
Unable 6 (5)
Do housework
Without help 70 (56)
With some help 44 (35)
Unable 11 (9)
Manage medications
Without help 110 (88)
With some help 15 (12)
Unable 0 (0)
Manage finances
Without help 105 (84)
With some help 17 (14)
Unable 3 (2)
Walk one block
Not limited at all 81 (65)
Limited a little 21 (17)
Limited a lot 23 (18)
Climb one flight of stairs
Not limited at all 69 (55)
Limited a little 32 (26)
Limited a lot 24 (19)
Abbreviation: KPS, Karnofsky performance status.
* Not all percentages add to 100% as a result of rounding.
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strates that oncology providers do not routinely document the
presence of falls in older patients with cancer. In the absence of
documentation of falls in the medical record, it is likely that
older patients who fall are going unrecognized by oncology
providers. Oncology providers need to be able to recognize falls
given that 50% of older adults with advanced cancer will expe-
rience a fall that is associated with a high risk of morbidity and
mortality.32,33 Because falls can result in functional declines 8,10
and cancer treatments place older patients at an increased risk of
falls,15,16 it is important for oncology providers to screen for
falls as part of a routine evaluation.
In lightof thenationwide shortageofgeriatricians,34 it is important
for oncology providers not only to screen for falls, but also to evaluate
and provide interventions or referrals as needed. Although some on-
cology providers (20%) in our sample did report a gait evaluation in
their physical exams, the majority of assessments were recorded as
normal or unremarkable. One explanation for this finding is that on-
cology providers may be uncertain about conducting or interpreting a
formal gait assessment. Knowing the basics of a falls evaluation is im-
portant for oncology providers in order to provide appropriate inter-
ventions. Commonly, older adults fall as a result of abnormalities in
gait,balancedisorders,and/ormuscularweakness.4Agaitassessment is
a simple evaluation that all clinicians can perform in clinic to assist in
determining the need for further interventions or referrals.
In this study, we collected information on referrals to PT,
OT, and/or geriatrics and found that only seven patients were
referred. Older adults who fall benefit from referrals to PT
and/or OT for further rehabilitation and exercise pro-
grams.24,25 On the basis of a review of the patients’ GA data,
almost 50% of patients in our study who reported a fall were
limited in their ability to climb a flight of stairs, and just over a
third were limited in their ability to walk one block. It is likely
these patients would have benefited from PT. Similarly, at least
44% of patients reported limitations in at least one IADL, for
which an OT referral would have been suggested. Referral to a
geriatrician could further assist with identification of and inter-
vention in other potential causes of falls such as polypharmacy,
frailty, and medical comorbidity.
Vitamin D deficiency is common in older adults26 and is
associated with balance problems,35 impaired lower extremity
function,36 and muscle weakness.7 Vitamin D supplementation
is an important intervention that was shown to reduce the risk
of falls by at least 20% in a meta-analysis of ambulatory and
institutionalized older adults.28 In our sample, vitamin D was
evaluated in 17% of patients who had a falls history, generally as
part of an osteoporosis evaluation for patients receiving endo-
crine therapy for breast cancer.
By ensuring adequate vitamin D supplementation, oncology
providers could easily provide an effective evidence-based inter-
vention known to reduce the risk of falls.7,27-29 Because vitamin
D deficiency is so common in older adults and has been associ-
ated with a variety of poor health outcomes,26,37 vitamin D
supplementation should be considered in all older patients with
cancer.
Our study has some limitations. Recruitment for the CSR
used in our study was done through nonrandomized sampling
of patients from oncology clinics, which could result in selec-
tion bias. Charts were retrospectively reviewed for only one
large academic site as a result of difficulties in obtaining chart
information from outside clinical locations, and may not be
representative of all clinical sites. Although our study found low
rates of documentation of falls, gait assessments, and referrals in
patients’ charts, it is possible that oncologists are performing
some of these activities but are not including the supporting
documentation in the medical record. An analysis of claims data
might have uncovered falls-related activities, to the extent that
such activities were billable.
These results, while dramatic, are not surprising given that
oncologists are not formally trained in the basic principles of
geriatric medicine. Oncology providers also have major time
constraints, limiting their ability to perform the expanded eval-
uations needed to assess the complex issues that affect many
older patients with cancer. This study demonstrates the need to
increase oncology providers’ awareness of falls, provides further
evidence that our current standard oncologic evaluation is miss-
ing this critical information, and highlights the need to include
falls screening as a routine component in the treatment of older
patients with cancer.
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Table 3. Results of Chart Reviews (N  125)
Outcomes No. (%) 95% CI
Falls documented 13 (10) 6% to 17%
Gait assessment 25 (20) 13% to 28%
Vitamin D level 21 (17) 11% to 25%
Referrals 7 (6) 2% to 11%
NOTE. Referrals  physical therapy, occupational therapy, and/or geriatrics.
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